ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

1998 Cancer Meetings Listed Through Oct.

January 9, 1998